Dudediligence.

Connect Biopharma Holdings Limited

CNTBNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

63.0M

on 2026-06-30, from 55.3M on 2024-12-31 10-Q ↗

a raise that quarter, at its price

20M40M60MDec2024Mar2025JunSepDecMar2026$3.25Jun

Newest

$300.0M

F-3 of 2025-06-10. Sales under the at-the-market programme filed with it are not stated apart. F-3 ↗

$150.0M

Cantor Fitzgerald, agreement of 2025-06-10. No at-the-market sales statement read from a 10-Q or 10-K. F-3 ↗

Warrants

The 10-Q filed 2026-08-12 is not read yet.

Cash

2.1 quarters

$31.5M on 2026-06-30 ÷ $15.1M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-03-29Private placementnot read$3.25$20.2M8-K ↗